{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:12:50Z","timestamp":1790885570913,"version":"4.1.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T00:00:00Z","timestamp":1372291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s12013-013-9698-1","type":"journal-article","created":{"date-parts":[[2013,6,26]],"date-time":"2013-06-26T05:47:29Z","timestamp":1372225649000},"page":"111-125","source":"Crossref","is-referenced-by-count":39,"title":["The Therapeutic Effects of Bone Marrow-Derived Mesenchymal Stem Cells and Simvastatin in a Rat Model of Liver Fibrosis"],"prefix":"10.1007","volume":"68","author":[{"given":"Tarek M. K.","family":"Motawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem M.","family":"Atta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermin A. H.","family":"Sadik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Azzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,27]]},"reference":[{"issue":"Suppl 1","key":"9698_CR1","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","volume":"38","author":"SL Friedman","year":"2003","unstructured":"Friedman, S. L. (2003). Liver fibrosis\u2014From bench to bedside. Journal of hepatology, 38(Suppl 1), S38\u2013S53.","journal-title":"Journal of hepatology"},{"key":"9698_CR2","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra035021","volume":"350","author":"P Gines","year":"2004","unstructured":"Gines, P., Cardenas, A., Arroyo, V., & Rodes, J. (2004). Management of cirrhosis and ascites. New England Journal of Medicine, 350, 1646\u20131654.","journal-title":"New England Journal of Medicine"},{"key":"9698_CR3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller, R., & Brenner, D. A. (2005). Liver fibrosis. The Journal of Clinical Investigation, 115, 209\u2013218.","journal-title":"The Journal of Clinical Investigation"},{"key":"9698_CR4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","volume":"46","author":"S Hemmann","year":"2007","unstructured":"Hemmann, S., Graf, J., Roderfeld, M., & Roeb, E. (2007). Expression of MMPs and TIMPs in liver fibrosis\u2014A systematic review with special emphasis on anti-fibrotic strategies. Journal of Hepatology, 46, 955\u2013975.","journal-title":"Journal of Hepatology"},{"key":"9698_CR5","first-page":"143","volume":"24","author":"M Consolo","year":"2009","unstructured":"Consolo, M., Amoroso, A., Spandidos, D., & Mazzarino, M. (2009). Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease (Review). International Journal of Molecular Medicine, 24, 143\u2013152.","journal-title":"International Journal of Molecular Medicine"},{"key":"9698_CR6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock, K., Plaks, V., & Werb, Z. (2010). Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell, 141, 52\u201367.","journal-title":"Cell"},{"key":"9698_CR7","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1600-6143.2008.02174.x","volume":"8","author":"RB Freeman Jr","year":"2008","unstructured":"Freeman, R. B., Jr., Steffick, D. E., Guidinger, M. K., Farmer, D. G., Berg, C. L., & Merion, R. M. (2008). Liver and intestine transplantation in the United States, 1997\u20132006. American Journal of Transplantation, 8, 958\u2013976.","journal-title":"American Journal of Transplantation"},{"key":"9698_CR8","first-page":"237","volume":"13","author":"AH Piersma","year":"1985","unstructured":"Piersma, A. H., Brockbank, K. G., Ploemacher, R. E., van Vliet, E., Brakel-van Peer, K. M., & Visser, P. J. (1985). Characterization of fibroblastic stromal cells from murine bone marrow. Experimental Hematology, 13, 237\u2013243.","journal-title":"Experimental Hematology"},{"key":"9698_CR9","unstructured":"Owen, M., & Friedenstein, A. J. (2007). Stromal stem cells: Marrow-derived osteogenic precursors. In Ciba Foundation Symposium 136\u2014Cell and Molecular Biology of Vertebrate Hard Tissues. Chichester: Wiley."},{"key":"9698_CR10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature00870","volume":"418","author":"Y Jiang","year":"2002","unstructured":"Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 418, 41\u201349.","journal-title":"Nature"},{"key":"9698_CR11","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJMoa051779","volume":"355","author":"B Assmus","year":"2006","unstructured":"Assmus, B., Honold, J., Schachinger, V., Britten, M. B., Fischer-Rasokat, U., Lehmann, R., et al. (2006). Transcoronary transplantation of progenitor cells after myocardial infarction. New England Journal of Medicine, 355, 1222\u20131232.","journal-title":"New England Journal of Medicine"},{"key":"9698_CR12","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ana.20501","volume":"57","author":"OY Bang","year":"2005","unstructured":"Bang, O. Y., Lee, J. S., Lee, P. H., & Lee, G. (2005). Autologous mesenchymal stem cell transplantation in stroke patients. Annals of Neurology, 57, 874\u2013882.","journal-title":"Annals of Neurology"},{"key":"9698_CR13","first-page":"185","volume":"2","author":"ZX Zhang","year":"2007","unstructured":"Zhang, Z. X., Zhang, Y. Z., Guan, L. X., Zhou, Y. J., Zhao, X. X., Cai, Y. H., et al. (2007). Autotransplantation of purified mesenchymal stem cells in a patient with acute myocardial infarction: A case study. Journal of Stem Cells, 2, 185\u2013189.","journal-title":"Journal of Stem Cells"},{"key":"9698_CR14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/14653240701883061","volume":"10","author":"ZX Zhang","year":"2008","unstructured":"Zhang, Z. X., Guan, L. X., Zhang, K., Zhang, Q., & Dai, L. J. (2008). A combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injury. Cytotherapy, 10, 134\u2013139.","journal-title":"Cytotherapy"},{"key":"9698_CR15","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1172\/JCI0215182","volume":"109","author":"RE Schwartz","year":"2002","unstructured":"Schwartz, R. E., Reyes, M., Koodie, L., Jiang, Y., Blackstad, M., Lund, T., et al. (2002). Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. The Journal of Clinical Investigation, 109, 1291\u20131302.","journal-title":"The Journal of Clinical Investigation"},{"key":"9698_CR16","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/hep.20469","volume":"40","author":"KD Lee","year":"2004","unstructured":"Lee, K. D., Kuo, T. K., Whang-Peng, J., Chung, Y. F., Lin, C. T., Chou, S. H., et al. (2004). In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology, 40, 1275\u20131284.","journal-title":"Hepatology"},{"key":"9698_CR17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.TP.0000128326.95294.14","volume":"78","author":"B Fang","year":"2004","unstructured":"Fang, B., Shi, M., Liao, L., Yang, S., Liu, Y., & Zhao, R. C. (2004). Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation, 78, 83\u201388.","journal-title":"Transplantation"},{"key":"9698_CR18","first-page":"14","volume":"3","author":"MK Oxana Lukivskaya","year":"2007","unstructured":"Oxana Lukivskaya, M. K., Dudzik, D., Borzym-Kluczyk, M., Lis, R., Buko, V., & Zwierz, K. (2007). Effects of statins on liver fibrosis reversibility and activities of lysosomal exoglycosidases. E&C Hepatology, 3, 14\u201317.","journal-title":"E&C Hepatology"},{"key":"9698_CR19","first-page":"483","volume":"59","author":"M Jasinska","year":"2007","unstructured":"Jasinska, M., Owczarek, J., & Orszulak-Michalak, D. (2007). Statins: A new insight into their mechanisms of action and consequent pleiotropic effects. Pharmacological Reports, 59, 483\u2013499.","journal-title":"Pharmacological Reports"},{"key":"9698_CR20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.295.1.74","volume":"295","author":"KM Dale","year":"2006","unstructured":"Dale, K. M., Coleman, C. I., Henyan, N. N., Kluger, J., & White, C. M. (2006). Statins and cancer risk: A meta-analysis. Journal of the American Medical Association, 295, 74\u201380.","journal-title":"Journal of the American Medical Association"},{"key":"9698_CR21","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1056\/NEJMoa043792","volume":"352","author":"JN Poynter","year":"2005","unstructured":"Poynter, J. N., Gruber, S. B., Higgins, P. D., Almog, R., Bonner, J. D., Rennert, H. S., et al. (2005). Statins and the risk of colorectal cancer. New England Journal of Medicine, 352, 2184\u20132192.","journal-title":"New England Journal of Medicine"},{"key":"9698_CR22","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2036.2006.03021.x","volume":"24","author":"EN Liberopoulos","year":"2006","unstructured":"Liberopoulos, E. N., Athyros, V. G., Elisaf, M. S., & Mikhailidis, D. P. (2006). Statins for non-alcoholic fatty liver disease: A new indication? Alimentary Pharmacology & Therapeutics, 24, 698\u2013699.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"9698_CR23","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1053\/j.gastro.2004.02.015","volume":"126","author":"N Chalasani","year":"2004","unstructured":"Chalasani, N., Aljadhey, H., Kesterson, J., Murray, M. D., & Hall, S. D. (2004). Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity. Gastroenterology, 126, 1287\u20131292.","journal-title":"Gastroenterology"},{"key":"9698_CR24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.CIR.99.2.185","volume":"99","author":"CD Furberg","year":"1999","unstructured":"Furberg, C. D. (1999). Natural statins and stroke risk. Circulation, 99, 185\u2013188.","journal-title":"Circulation"},{"key":"9698_CR25","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1089\/scd.2004.13.436","volume":"13","author":"A Alhadlaq","year":"2004","unstructured":"Alhadlaq, A., & Mao, J. J. (2004). Mesenchymal stem cells: Isolation and therapeutics. Stem Cells and Development, 13, 436\u2013448.","journal-title":"Stem Cells and Development"},{"key":"9698_CR26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2613.2008.00607.x","volume":"89","author":"K Moriya","year":"2008","unstructured":"Moriya, K., Yoshikawa, M., Ouji, Y., Saito, K., Nishiofuku, M., Matsuda, R., et al. (2008). Embryonic stem cells reduce liver fibrosis in CCl4-treated mice. International Journal of Experimental Pathology, 89, 401\u2013409.","journal-title":"International Journal of Experimental Pathology"},{"key":"9698_CR27","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.3748\/wjg.v11.i22.3431","volume":"11","author":"DC Zhao","year":"2005","unstructured":"Zhao, D. C., Lei, J. X., Chen, R., Yu, W. H., Zhang, X. M., Li, S. N., et al. (2005). Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World Journal of Gastroenterology, 11, 3431\u20133440.","journal-title":"World Journal of Gastroenterology"},{"key":"9698_CR28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1172\/JCI103055","volume":"34","author":"A Karmen","year":"1955","unstructured":"Karmen, A. (1955). A note on the spectrometric assay of glutamic-oxalacetic transaminase in human blood serum. The Journal of Clinical Investigation, 34, 131\u2013133.","journal-title":"The Journal of Clinical Investigation"},{"key":"9698_CR29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ajcp\/28.1.56","volume":"28","author":"S Reitman","year":"1957","unstructured":"Reitman, S., & Frankel, S. (1957). A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. American Journal of Clinical Pathology, 28, 56\u201363.","journal-title":"American Journal of Clinical Pathology"},{"key":"9698_CR30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/jcp.7.4.322","volume":"7","author":"PR Kind","year":"1954","unstructured":"Kind, P. R., & King, E. J. (1954). Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine. Journal of Clinical Pathology, 7, 322\u2013326.","journal-title":"Journal of Clinical Pathology"},{"key":"9698_CR31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1159\/000459586","volume":"12","author":"A Belfield","year":"1971","unstructured":"Belfield, A., & Goldberg, D. M. (1971). Revised assay for serum phenyl phosphatase activity using 4-amino-antipyrine. Enzyme, 12, 561\u2013573.","journal-title":"Enzyme"},{"key":"9698_CR32","first-page":"518","volume-title":"Clinical guide to laboratory tests","author":"NW Tietz","year":"1995","unstructured":"Tietz, N. W. (1995). Clinical guide to laboratory tests (pp. 518\u2013522). Philadelphia, PA: WB Saunders Company."},{"key":"9698_CR33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0009-8981(71)90365-2","volume":"31","author":"BT Doumas","year":"1971","unstructured":"Doumas, B. T., Watson, W. A., & Biggs, H. G. (1971). Albumin standards and the measurement of serum albumin with bromocresol green. Clinica Chimica Acta; International Journal of Clinical Chemistry, 31, 87\u201396.","journal-title":"Clinica Chimica Acta; International Journal of Clinical Chemistry"},{"key":"9698_CR34","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1634\/stemcells.2004-0013","volume":"22","author":"HS Wang","year":"2004","unstructured":"Wang, H. S., Hung, S. C., Peng, S. T., Huang, C. C., Wei, H. M., Guo, Y. J., et al. (2004). Mesenchymal stem cells in the Wharton\u2019s jelly of the human umbilical cord. Stem Cells, 22, 1330\u20131337.","journal-title":"Stem Cells"},{"key":"9698_CR35","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/01.TP.0000066362.37931.6D","volume":"76","author":"GD Wu","year":"2003","unstructured":"Wu, G. D., Tuan, T. L., Bowdish, M. E., Jin, Y. S., Starnes, V. A., Cramer, D. V., et al. (2003). Evidence for recipient derived fibroblast recruitment and activation during the development of chronic cardiac allograft rejection. Transplantation, 76, 609\u2013614.","journal-title":"Transplantation"},{"key":"9698_CR36","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.clinbiochem.2007.04.017","volume":"40","author":"MT Abdel Aziz","year":"2007","unstructured":"Abdel Aziz, M. T., Atta, H. M., Mahfouz, S., Fouad, H. H., Roshdy, N. K., Ahmed, H. H., et al. (2007). Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clinical Biochemistry, 40, 893\u2013899.","journal-title":"Clinical Biochemistry"},{"key":"9698_CR37","doi-asserted-by":"crossref","unstructured":"Scheuer, P. J., Standish, R. A., & Dhillon, A. P. (2002). Scoring of chronic hepatitis. Clinics in Liver Disease, 6, 335\u2013347, v\u2013vi.","DOI":"10.1016\/S1089-3261(02)00009-0"},{"key":"9698_CR38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa, P., Poynard, T., & The METAVIR Cooperative Study Group. (1996). An algorithm for the grading of activity in chronic hepatitis C. Hepatology, 24, 289\u2013293.","journal-title":"Hepatology"},{"key":"9698_CR39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1124\/jpet.300.1.273","volume":"300","author":"JV Bruckner","year":"2002","unstructured":"Bruckner, J. V., Ramanathan, R., Lee, K. M., & Muralidhara, S. (2002). Mechanisms of circadian rhythmicity of carbon tetrachloride hepatotoxicity. Journal of Pharmacology and Experimental Therapeutics, 300, 273\u2013281.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"9698_CR40","first-page":"55","volume":"5","author":"P Roy-Chaudhury","year":"1997","unstructured":"Roy-Chaudhury, P., Simpson, J. G., & Power, D. A. (1997). Endoglin, a transforming growth factor-beta-binding protein, is upregulated in chronic progressive renal disease. Experimental Nephrology, 5, 55\u201360.","journal-title":"Experimental Nephrology"},{"key":"9698_CR41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0016-5085(95)90029-2","volume":"108","author":"C Garcia-Monzon","year":"1995","unstructured":"Garcia-Monzon, C., Sanchez-Madrid, F., Garcia-Buey, L., Garcia-Arroyo, A., Garcia-Sanchez, A., & Moreno-Otero, R. (1995). Vascular adhesion molecule expression in viral chronic hepatitis: Evidence of neoangiogenesis in portal tracts. Gastroenterology, 108, 231\u2013241.","journal-title":"Gastroenterology"},{"key":"9698_CR42","doi-asserted-by":"crossref","first-page":"19027","DOI":"10.1016\/S0021-9258(18)41732-2","volume":"267","author":"S Cheifetz","year":"1992","unstructured":"Cheifetz, S., Bellon, T., Cales, C., Vera, S., Bernabeu, C., Massague, J., et al. (1992). Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. The Journal of Biological Chemistry, 267, 19027\u201319030.","journal-title":"The Journal of Biological Chemistry"},{"key":"9698_CR43","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1083\/jcb.133.5.1109","volume":"133","author":"P Lastres","year":"1996","unstructured":"Lastres, P., Letamendia, A., Zhang, H., Rius, C., Almendro, N., Raab, U., et al. (1996). Endoglin modulates cellular responses to TGF-beta 1. Journal of Cell Biology, 133, 1109\u20131121.","journal-title":"Journal of Cell Biology"},{"key":"9698_CR44","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/hep.21135","volume":"43","author":"E Wiercinska","year":"2006","unstructured":"Wiercinska, E., Wickert, L., Denecke, B., Said, H. M., Hamzavi, J., Gressner, A. M., et al. (2006). Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells. Hepatology, 43, 1032\u20131041.","journal-title":"Hepatology"},{"key":"9698_CR45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/gut.2006.111617","volume":"57","author":"LV Bonzo di","year":"2008","unstructured":"di Bonzo, L. V., Ferrero, I., Cravanzola, C., Mareschi, K., Rustichell, D., Novo, E., et al. (2008). Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: Engraftment and hepatocyte differentiation versus profibrogenic potential. Gut, 57, 223\u2013231.","journal-title":"Gut"},{"key":"9698_CR46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn, T. A. (2008). Cellular and molecular mechanisms of fibrosis. The Journal of Pathology, 214, 199\u2013210.","journal-title":"The Journal of Pathology"},{"key":"9698_CR47","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00019501-200506000-00006","volume":"16","author":"X Xu","year":"2005","unstructured":"Xu, X., Xu, Z., Xu, Y., & Cui, G. (2005). Effects of mesenchymal stem cell transplantation on extracellular matrix after myocardial infarction in rats. Coronary Artery Disease, 16, 245\u2013255.","journal-title":"Coronary Artery Disease"},{"key":"9698_CR48","doi-asserted-by":"crossref","first-page":"e941","DOI":"10.1371\/journal.pone.0000941","volume":"2","author":"B Parekkadan","year":"2007","unstructured":"Parekkadan, B., van Poll, D., Suganuma, K., Carter, E. A., Berthiaume, F., Tilles, A. W., et al. (2007). Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS ONE, 2, e941.","journal-title":"PLoS ONE"},{"key":"9698_CR49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.scr.2008.07.005","volume":"2","author":"LJ Dai","year":"2009","unstructured":"Dai, L. J., Li, H. Y., Guan, L. X., Ritchie, G., & Zhou, J. X. (2009). The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis. Stem Cell Research, 2, 16\u201325.","journal-title":"Stem Cell Research"},{"issue":"Suppl 1","key":"9698_CR50","doi-asserted-by":"crossref","first-page":"11850","DOI":"10.1073\/pnas.1834198100","volume":"100","author":"Y Kanazawa","year":"2003","unstructured":"Kanazawa, Y., & Verma, I. M. (2003). Little evidence of bone marrow-derived hepatocytes in the replacement of injured liver. Proceedings of the National Academy of Sciences of the United States of America, 100(Suppl 1), 11850\u201311853.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9698_CR51","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/01.CIR.0000124062.31102.57","volume":"109","author":"T Kinnaird","year":"2004","unstructured":"Kinnaird, T., Stabile, E., Burnett, M. S., Shou, M., Lee, C. W., Barr, S., et al. (2004). Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation, 109, 1543\u20131549.","journal-title":"Circulation"},{"key":"9698_CR52","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/01.CIR.0000151812.86142.45","volume":"111","author":"GV Silva","year":"2005","unstructured":"Silva, G. V., Litovsky, S., Assad, J. A., Sousa, A. L., Martin, B. J., Vela, D., et al. (2005). Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation, 111, 150\u2013156.","journal-title":"Circulation"},{"key":"9698_CR53","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.exphem.2004.06.012","volume":"32","author":"Y Matsuda-Hashii","year":"2004","unstructured":"Matsuda-Hashii, Y., Takai, K., Ohta, H., Fujisaki, H., Tokimasa, S., Osugi, Y., et al. (2004). Hepatocyte growth factor plays roles in the induction and autocrine maintenance of bone marrow stromal cell IL-11, SDF-1 alpha, and stem cell factor. Experimental Hematology, 32, 955\u2013961.","journal-title":"Experimental Hematology"},{"key":"9698_CR54","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/5593","volume":"5","author":"T Ueki","year":"1999","unstructured":"Ueki, T., Kaneda, Y., Tsutsui, H., Nakanishi, K., Sawa, Y., Morishita, R., et al. (1999). Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nature Medicine, 5, 226\u2013230.","journal-title":"Nature Medicine"},{"key":"9698_CR55","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1212\/WNL.59.4.514","volume":"59","author":"Y Li","year":"2002","unstructured":"Li, Y., Chen, J., Chen, X. G., Wang, L., Gautam, S. C., Xu, Y. X., et al. (2002). Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery. Neurology, 59, 514\u2013523.","journal-title":"Neurology"},{"key":"9698_CR56","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0002-9440(10)64994-2","volume":"156","author":"N Trim","year":"2000","unstructured":"Trim, N., Morgan, S., Evans, M., Issa, R., Fine, D., Afford, S., et al. (2000). Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation. The American Journal of Pathology, 156, 1235\u20131243.","journal-title":"The American Journal of Pathology"},{"key":"9698_CR57","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1440-1789.2002.00450.x","volume":"22","author":"X Chen","year":"2002","unstructured":"Chen, X., Li, Y., Wang, L., Katakowski, M., Zhang, L., Chen, J., et al. (2002). Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology: Official Journal of the Japanese Society of Neuropathology, 22, 275\u2013279.","journal-title":"Neuropathology: Official Journal of the Japanese Society of Neuropathology"},{"key":"9698_CR58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1084\/jem.185.1.111","volume":"185","author":"A Aiuti","year":"1997","unstructured":"Aiuti, A., Webb, I. J., Bleul, C., Springer, T., & Gutierrez-Ramos, J. C. (1997). The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. The Journal of Experimental Medicine, 185, 111\u2013120.","journal-title":"The Journal of Experimental Medicine"},{"key":"9698_CR59","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2121-12-44","volume":"12","author":"FZ Asumda","year":"2011","unstructured":"Asumda, F. Z., & Chase, P. B. (2011). Age-related changes in rat bone-marrow mesenchymal stem cell plasticity. BMC Cell Biology, 12, 44.","journal-title":"BMC Cell Biology"},{"key":"9698_CR60","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0168-8278(03)00051-5","volume":"38","author":"K Rombouts","year":"2003","unstructured":"Rombouts, K., Kisanga, E., Hellemans, K., Wielant, A., Schuppan, D., & Geerts, A. (2003). Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells. Journal of Hepatology, 38, 564\u2013572.","journal-title":"Journal of Hepatology"},{"key":"9698_CR61","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/1529-0131(200007)43:7<1624::AID-ANR28>3.0.CO;2-E","volume":"43","author":"J Rosenbloom","year":"2000","unstructured":"Rosenbloom, J., Saitta, B., Gaidarova, S., Sandorfi, N., Rosenbloom, J. C., Abrams, W. R., et al. (2000). Inhibition of type I collagen gene expression in normal and systemic sclerosis fibroblasts by a specific inhibitor of geranylgeranyl transferase I. Arthritis and Rheumatism, 43, 1624\u20131632.","journal-title":"Arthritis and Rheumatism"},{"key":"9698_CR62","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","volume":"343","author":"JL Goldstein","year":"1990","unstructured":"Goldstein, J. L., & Brown, M. S. (1990). Regulation of the mevalonate pathway. Nature, 343, 425\u2013430.","journal-title":"Nature"},{"key":"9698_CR63","doi-asserted-by":"crossref","first-page":"10678","DOI":"10.1074\/jbc.M111369200","volume":"277","author":"SA Holstein","year":"2002","unstructured":"Holstein, S. A., Wohlford-Lenane, C. L., & Hohl, R. J. (2002). Consequences of mevalonate depletion. Differential transcriptional, translational, and post-translational up-regulation of Ras, Rap1a, RhoA, and RhoB. The Journal of Biological Chemistry, 277, 10678\u201310682.","journal-title":"The Journal of Biological Chemistry"},{"key":"9698_CR64","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/art.21723","volume":"54","author":"N Louneva","year":"2006","unstructured":"Louneva, N., Huaman, G., Fertala, J., & Jimenez, S. A. (2006). Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin. Arthritis and Rheumatism, 54, 1298\u20131308.","journal-title":"Arthritis and Rheumatism"},{"key":"9698_CR65","doi-asserted-by":"crossref","first-page":"24266","DOI":"10.1074\/jbc.273.37.24266","volume":"273","author":"U Laufs","year":"1998","unstructured":"Laufs, U., & Liao, J. K. (1998). Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. The Journal of Biological Chemistry, 273, 24266\u201324271.","journal-title":"The Journal of Biological Chemistry"},{"issue":"12","key":"9698_CR66","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.RES.0000196564.18314.23","volume":"97","author":"Y Rikitake","year":"2005","unstructured":"Rikitake, Y., & Liao, J. K. (2005). Rho GTPases, statins, and nitric oxide. Circulation Research, 97(12), 1232\u20131235.","journal-title":"Circulation Research"},{"key":"9698_CR67","first-page":"3517","volume":"26","author":"WI Jeong","year":"2006","unstructured":"Jeong, W. I., Do, S. H., Jeong, D. H., Hong, I. H., Park, J. K., Ran, K. M., et al. (2006). Kinetics of MMP-1 and MMP-3 produced by mast cells and macrophages in liver fibrogenesis of rat. Anticancer Research, 26, 3517\u20133526.","journal-title":"Anticancer Research"},{"key":"9698_CR68","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1164\/ajrccm.159.1.9802104","volume":"159","author":"A Tan","year":"1999","unstructured":"Tan, A., Levrey, H., Dahm, C., Polunovsky, V. A., Rubins, J., & Bitterman, P. B. (1999). Lovastatin induces fibroblast apoptosis in vitro and in vivo. A possible therapy for fibroproliferative disorders. American Journal of Respiratory and Critical Care Medicine, 159, 220\u2013227.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"9698_CR69","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0168-8278(02)00006-5","volume":"36","author":"U Ritzel","year":"2002","unstructured":"Ritzel, U., Leonhardt, U., Nather, M., Schafer, G., Armstrong, V. W., & Ramadori, G. (2002). Simvastatin in primary biliary cirrhosis: Effects on serum lipids and distinct disease markers. Journal of Hepatology, 36, 454\u2013458.","journal-title":"Journal of Hepatology"},{"key":"9698_CR70","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/hep.21848","volume":"46","author":"JH Lewis","year":"2007","unstructured":"Lewis, J. H., Mortensen, M. E., Zweig, S., Fusco, M. J., Medoff, J. R., & Belder, R. (2007). Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Hepatology, 46, 1453\u20131463.","journal-title":"Hepatology"},{"key":"9698_CR71","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.amjmed.2006.07.033","volume":"120","author":"KM Dale","year":"2007","unstructured":"Dale, K. M., White, C. M., Henyan, N. N., Kluger, J., & Coleman, C. I. (2007). Impact of statin dosing intensity on transaminase and creatine kinase. The American Journal of Medicine, 120, 706\u2013712.","journal-title":"The American Journal of Medicine"},{"key":"9698_CR72","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/hep.20671","volume":"41","author":"N Chalasani","year":"2005","unstructured":"Chalasani, N. (2005). Statins and hepatotoxicity: Focus on patients with fatty liver. Hepatology, 41, 690\u2013695.","journal-title":"Hepatology"},{"key":"9698_CR73","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1742-1241.2007.01666.x","volume":"62","author":"P Riley","year":"2008","unstructured":"Riley, P., Sudarshi, D., Johal, M., Benedict, A., Panteli, J., Crook, M., et al. (2008). Weight loss, dietary advice and statin therapy in non-alcoholic fatty liver disease: A retrospective study. International Journal of Clinical Practice, 62, 374\u2013381.","journal-title":"International Journal of Clinical Practice"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-013-9698-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12013-013-9698-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-013-9698-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T12:05:51Z","timestamp":1645877151000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12013-013-9698-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,27]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["9698"],"URL":"https:\/\/doi.org\/10.1007\/s12013-013-9698-1","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,27]]}}}